ESBRIET
· Patent Litigation & Settlement History ↓
Current GenericRadar decision
GNR judgment: DISCONTINUED. Reference year: 2017. Anchor type: DISCONTINUED. Patent anchor: not recorded. Exclusivity anchor: not recorded. Anchor date: not recorded. Patent tail: not established. Exclusivity tail: not established. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.
Patent estate
| Patent | Effective date | Official listing | TRUE_DS | DS grade | Claim classification / basis | PTE | PED | Family |
|---|---|---|---|---|---|---|---|---|
| 7767700 | 2027-12-18 | U U-2080 | — | — | — | — | — | — |
| 8420674 | 2027-12-18 | U U-2079 | — | — | — | — | — | — |
| 8383150 | 2028-05-10 | DP/U U-2361 | — | — | — | — | — | — |
| 7566729 | 2029-04-22 | U U-2269 | — | — | — | — | — | — |
| 7566729 | 2029-04-22 | U U-2270 | — | — | — | — | — | — |
| 7635707 | 2029-04-22 | U U-2073 | — | — | — | — | — | — |
| 7635707 | 2029-04-22 | U U-2075 | — | — | — | — | — | — |
| 7635707 | 2029-04-22 | U U-2074 | — | — | — | — | — | — |
| 7635707 | 2029-04-22 | U U-2072 | — | — | — | — | — | — |
| 7635707 | 2029-04-22 | U U-2083 | — | — | — | — | — | — |
| 7635707 | 2029-04-22 | U U-2076 | — | — | — | — | — | — |
| 8592462 | 2029-04-22 | U U-2056 | — | — | — | — | — | — |
| 8592462 | 2029-04-22 | U U-2062 | — | — | — | — | — | — |
| 8592462 | 2029-04-22 | U U-2055 | — | — | — | — | — | — |
| 8592462 | 2029-04-22 | U U-2059 | — | — | — | — | — | — |
| 8592462 | 2029-04-22 | U U-2061 | — | — | — | — | — | — |
| 8592462 | 2029-04-22 | U U-2060 | — | — | — | — | — | — |
| 8592462 | 2029-04-22 | U U-2063 | — | — | — | — | — | — |
| 8592462 | 2029-04-22 | U U-2058 | — | — | — | — | — | — |
| 8592462 | 2029-04-22 | U U-2057 | — | — | — | — | — | — |
| 8609701 | 2029-04-22 | U U-2068 | — | — | — | — | — | — |
| 8609701 | 2029-04-22 | U U-2070 | — | — | — | — | — | — |
| 8609701 | 2029-04-22 | U U-2064 | — | — | — | — | — | — |
| 8609701 | 2029-04-22 | U U-2066 | — | — | — | — | — | — |
| 8609701 | 2029-04-22 | U U-2067 | — | — | — | — | — | — |
| 8609701 | 2029-04-22 | U U-2069 | — | — | — | — | — | — |
| 8609701 | 2029-04-22 | U U-2065 | — | — | — | — | — | — |
| 7816383 | 2030-01-08 | U U-2050 | — | — | — | — | — | — |
| 7816383 | 2030-01-08 | U U-2042 | — | — | — | — | — | — |
| 7910610 | 2030-01-08 | U U-2049 | — | — | — | — | — | — |
| 7910610 | 2030-01-08 | U U-2048 | — | — | — | — | — | — |
| 8013002 | 2030-01-08 | U U-2082 | — | — | — | — | — | — |
| 8013002 | 2030-01-08 | U U-2047 | — | — | — | — | — | — |
| 8084475 | 2030-01-08 | U U-2054 | — | — | — | — | — | — |
| 8084475 | 2030-01-08 | U U-2268 | — | — | — | — | — | — |
| 8318780 | 2030-01-08 | U U-2081 | — | — | — | — | — | — |
| 8318780 | 2030-01-08 | U U-2046 | — | — | — | — | — | — |
| 8648098 | 2030-01-08 | U U-2052 | — | — | — | — | — | — |
| 8648098 | 2030-01-08 | U U-2051 | — | — | — | — | — | — |
| 8754109 | 2030-01-08 | U U-2053 | — | — | — | — | — | — |
| 8778947 | 2033-08-30 | U U-2045 | — | — | — | — | — | — |
| 8778947 | 2033-08-30 | U U-2044 | — | — | — | — | — | — |
| 10188637 | 2037-03-28 | DP — | — | — | — | — | — | — |
Regulatory exclusivity
| Code | Start date | End date | Scope | Entire product | All indications | Full coverage date | Combination | Source |
|---|---|---|---|---|---|---|---|---|
| No exclusivity facts are recorded in this product snapshot. | ||||||||
2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE
Generic approval evidence
| Application / product | Event | Final date | Tentative date | Applicant | Authorized generic | Exact mapping | Source |
|---|---|---|---|---|---|---|---|
| No generic approval facts are linked to this product. | |||||||
Market Entry Information
API filings, authorized generics and linked regulatory milestones.
API Master Files & Certifications 0 records
Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.
| API | Holder / manufacturer | Holder country | Filing type | Number | Status | Filed date | Available for reference | Source | Last verified |
|---|---|---|---|---|---|---|---|---|---|
| No master-file or certification records are linked through public manufacturer portfolios. | |||||||||
Authorized Generics 0 records
Authorized generics are shown separately from independent ANDA approvals.
| Application / product | Applicant | Event / status | First marketed | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No authorized-generic records are linked to this product. | ||||||
Tentative ANDA Approvals 0 records
Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.
| Application / product | Applicant | Event / status | Tentative date | Follow-up final approval | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|---|
| No tentative-approval records are linked to this product. | |||||||
Paragraph IV Challenges 0 records
Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.
| Application / product | Applicant | Event / status | Certification event date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No structured Paragraph IV certification events are linked in the available approval evidence. | ||||||
Final ANDA Approvals 0 records
Approval dates do not establish commercial launch. Product mapping is shown for each linked record.
| Application / product | Applicant | Event / status | Final approval date | Product mapping | Source | Last verified |
|---|---|---|---|---|---|---|
| No final-approval records are linked to this product. | ||||||
Litigation & Settlement History
Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.
No litigation or settlement record currently linked to this product.